fda-approvals

A Once-a-Day Rx for Type 2 Diabetes

Synjardy XR (empagliflozin/metformin hydrochloride) approved to treat type 2 diabetes

By RxWiki Staff

December 19, 2016 · 1 min read

The US Food and Drug Administration has approved a once-a-day medication to treat type 2 diabetes.

That medication is Synjardy XR, which is a combination of two medications: empagliflozin and metformin hydrochloride.

Synjardy XR is available as an extended-release tablet to be taken once a day.

The duo of empagliflozin and metformin hydrochloride was approved in combination with diet and exercise to lower blood sugar in adults with type 2 diabetes.

This medication received approval as a result of multiple clinical trials. Common side effects include nausea, vomiting, diarrhea and gas.

Synjardy XR should not be used in those with type 1 diabetes or diabetic ketoacidosis, a condition in which the blood or urine contains large amounts of ketone.

Serious side effects may occur in some people who take this medication. These include a buildup of lactic acid in the blood called lactic acidosis.

Synjardy XR is marketed by Boehringer Ingelheim and Eli Lilly and Company.

Written by

RxWiki Staff

Editorial Team

All information on this site is provided “as-is” for informational purposes only and is not a substitute for medical advice or treatment. You should consult with a medical professional if you have any questions about your health.